Table III.
Marker | Mifamurtide Infusion duration, min | aMean (%CV) bEmax (pg/mL) | Mean (%CV) cAUEC0-tlast (hr.pg/ml) | Median (range) TEmax (hr) |
---|---|---|---|---|
dTNF-alpha | 60 | 412 (105) | 2460 (82.1) | 4.00 (2.00–4.00) |
30 | 582 (96.9) | 2260 (86.0) | 2.05 (1.00–4.00) | |
eIL-6 | 60 | 895 (94.1) | 4650 (177) | 4.00 (2.00–4.08) |
30 | 811 (112.0) | 2200 (174) | 4.00 (2.00–4.08) |
%CV: coefficient of variation;
Emax: maximum pharmacodynamic effect;
AUEC0-tlast: area under the effect the time curve from time 0 to time of last quantifiable effect;
TNF-alpha: tumor necrosis factor alpha;
IL-6: interleukin-6